From empiricism to rational design: a personal perspective of the evolution of vaccine development

被引:150
作者
De Gregorio, Ennio [1 ]
Rappuoli, Rino [1 ]
机构
[1] Novartis Vaccines, I-53100 Siena, Italy
关键词
PNEUMOCOCCAL CONJUGATE VACCINE; CELL-MEDIATED-IMMUNITY; YELLOW-FEVER VACCINE; HEPATITIS-B-VACCINE; HIV-1; VACCINE; VIRUS-VACCINE; HAEMOPHILUS-INFLUENZAE; CANDIDATE ANTIGENS; CONTROLLED-TRIAL; ADJUVANT SYSTEM;
D O I
10.1038/nri3694
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vaccination, which is the most effective medical intervention that has ever been introduced, originated from the observation that individuals who survived a plague or smallpox would not get the disease twice. To mimic the protective effects of natural infection, Jenner-and later Pasteur-inoculated individuals with attenuated or killed disease-causing agents. This empirical approach inspired a century of vaccine development and the effective prophylaxis of many infectious diseases. From the 1980s, several waves of new technologies have enabled the development of novel vaccines that would not have been possible using the empirical approach. The technological revolution in the field of vaccination is now continuing, and it is delivering novel and safer vaccines. In this Timeline article, we provide our views on the transition from empiricism to rational vaccine design.
引用
收藏
页码:505 / 514
页数:10
相关论文
共 113 条
[1]   Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: Results of an open-label, randomized, phase 3b controlled study in healthy infants [J].
Abdelnour, Arturo ;
Silas, Peter E. ;
Lamas, Marta Raquel Valdes ;
Grazioso Aragon, Carlos Fernando ;
Chiu, Nan-Chang ;
Chiu, Cheng-Hsun ;
Acuna, Teobaldo Herrera ;
Castrejon, Tirza De Leon ;
Izu, Allen ;
Odrljin, Tatjana ;
Smolenov, Igor ;
Hohenboken, Matthew ;
Dull, Peter M. .
VACCINE, 2014, 32 (08) :965-972
[2]  
AERAS, 2014, CRUCELL AD35 MVA85A
[3]   Transferrin receptors of Neisseria meningitidis: Promising candidates for a broadly cross-protective vaccine [J].
AlaAldeen, DAA .
JOURNAL OF MEDICAL MICROBIOLOGY, 1996, 44 (04) :237-243
[4]   IMMUNIZATION OF HUMANS WITH POLYRIBOPHOSPHATE, CAPSULAR ANTIGEN OF HEMOPHILUS-INFLUENZAE, TYPE-B [J].
ANDERSON, P ;
JOHNSTON, RB ;
SMITH, DH ;
WETTERLOW, LH ;
PETER, G .
JOURNAL OF CLINICAL INVESTIGATION, 1972, 51 (01) :39-+
[5]  
[Anonymous], 2013, FACTSHEET
[6]  
[Anonymous], FLUVIEW: A Weekly Influenza Surveillance Report Prepared by the Influenza Division
[7]  
[Anonymous], GLOB TUB REP 2013
[8]  
[Anonymous], 2013, SCIENCE, V342, P1442
[9]   SEPARATION AND CHARACTERIZATION OF 2 DISTINCT HEMAGGLUTININS CONTAINED IN PURIFIED LEUKOCYTOSIS-PROMOTING FACTOR FROM BORDETELLA-PERTUSSIS [J].
ARAI, H ;
SATO, Y .
BIOCHIMICA ET BIOPHYSICA ACTA, 1976, 444 (03) :765-782
[10]   PROTECTIVE EFFICACY OF MOUSE SERUM TO THE N-PROPIONYL DERIVATIVE OF MENINGOCOCCAL GROUP-B POLYSACCHARIDE [J].
ASHTON, FE ;
RYAN, JA ;
MICHON, F ;
JENNINGS, HJ .
MICROBIAL PATHOGENESIS, 1989, 6 (06) :455-458